Skip to Content

MiMedx Group Inc MDXG

Morningstar Rating
$8.63 +0.47 (5.76%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MDXG is trading at a 1% discount.
Price
$8.66
Fair Value
$1.16
Uncertainty
Very High
1-Star Price
$71.17
5-Star Price
$9.77
Economic Moat
Kldrcjq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDXG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$8.16
Day Range
$8.298.73
52-Week Range
$3.089.27
Bid/Ask
$8.63 / $9.10
Market Cap
$1.26 Bil
Volume/Avg
2 / 744,805

Key Statistics

Price/Earnings (Normalized)
90.87
Price/Sales
3.92
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
867

Comparables

Valuation

Metric
MDXG
ANGO
ATEC
Price/Earnings (Normalized)
90.87
Price/Book Value
8.850.5523.92
Price/Sales
3.920.663.37
Price/Cash Flow
23.61
Price/Earnings
MDXG
ANGO
ATEC

Financial Strength

Metric
MDXG
ANGO
ATEC
Quick Ratio
2.951.441.86
Current Ratio
3.572.382.86
Interest Coverage
5.74−8.44−10.23
Quick Ratio
MDXG
ANGO
ATEC

Profitability

Metric
MDXG
ANGO
ATEC
Return on Assets (Normalized)
12.48%−1.36%−9.88%
Return on Equity (Normalized)
123.45%−1.78%
Return on Invested Capital (Normalized)
42.32%−1.46%−9.93%
Return on Assets
MDXG
ANGO
ATEC
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWsnf$550.4 Bil
VRTX
Vertex Pharmaceuticals IncBxmcjs$111.8 Bil
REGN
Regeneron Pharmaceuticals IncQbrlhlt$107.9 Bil
MRNA
Moderna IncMdst$36.3 Bil
ARGX
argenx SE ADRZtb$23.0 Bil
BNTX
BioNTech SE ADRPvzn$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncXmdtj$19.2 Bil
BMRN
Biomarin Pharmaceutical IncZydhgl$16.4 Bil
RPRX
Royalty Pharma PLC Class ABstqtg$13.4 Bil
INCY
Incyte CorpHmbtth$13.3 Bil

Sponsor Center